On January 27, 2017, Immunomedics, Inc. issued a statement to stockholders and announced it has filed an investor presentation with the Securities and Exchange Commission titled ‘The Right Board and the Right Strategy to Maximize Stockholder Value.’ The presentation is available on the SEC’s website at www.sec.gov and will also be available on the Company’s website at www.immunomedics.com/investors.shtml.